2004
DOI: 10.1016/j.actatropica.2002.03.001
|View full text |Cite
|
Sign up to set email alerts
|

Predicting the timing of second praziquantel treatment and its effect on reduction of egg counts in southern Ghana

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3

Citation Types

0
2
1

Year Published

2006
2006
2018
2018

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 7 publications
(3 citation statements)
references
References 8 publications
0
2
1
Order By: Relevance
“…Contrary to findings of Nsowah-Nuamah et al [25] in a study in Ghana where the prevalence of infection was reduced by 80–90% at 12 months after treatment, the prevalence in the current study was reduced by 91.6% only for 6 months which was reduced to 69.1% by the 12th month due to maturation of juvenile parasites that were not susceptible to the praziquantel [22] which have started oviposition and new infections. Therefore, our findings necessitate re-treatment with praziquantel after 12 months when prevalence increased contrary to the studies in Ghana [25] and Burkina Faso [16]. Although this is contrary to WHO [26] recommendation that communities with moderate risk (≥10% but <50% prevalence) should treat once every 2 years.…”
Section: Discussioncontrasting
confidence: 99%
See 1 more Smart Citation
“…Contrary to findings of Nsowah-Nuamah et al [25] in a study in Ghana where the prevalence of infection was reduced by 80–90% at 12 months after treatment, the prevalence in the current study was reduced by 91.6% only for 6 months which was reduced to 69.1% by the 12th month due to maturation of juvenile parasites that were not susceptible to the praziquantel [22] which have started oviposition and new infections. Therefore, our findings necessitate re-treatment with praziquantel after 12 months when prevalence increased contrary to the studies in Ghana [25] and Burkina Faso [16]. Although this is contrary to WHO [26] recommendation that communities with moderate risk (≥10% but <50% prevalence) should treat once every 2 years.…”
Section: Discussioncontrasting
confidence: 99%
“…According to Toure et al [16], the reduction in the intensity is particularly of importance as high intensity of S. haematobium infection has been shown to contribute to morbidity seen in schistosomiasis infection which includes anaemia in children [24]. Contrary to findings of Nsowah-Nuamah et al [25] in a study in Ghana where the prevalence of infection was reduced by 80–90% at 12 months after treatment, the prevalence in the current study was reduced by 91.6% only for 6 months which was reduced to 69.1% by the 12th month due to maturation of juvenile parasites that were not susceptible to the praziquantel [22] which have started oviposition and new infections. Therefore, our findings necessitate re-treatment with praziquantel after 12 months when prevalence increased contrary to the studies in Ghana [25] and Burkina Faso [16].…”
Section: Discussionmentioning
confidence: 99%
“…Impact of treatment varies according to region and treatment strategy. An annual treatment strategy has significantly reduced prevalence of schistosomiasis 1, 2, and 3 years post-treatment in West Africa, i.e., Burkina Faso [38], Niger [55], Ghana [56]; East Africa i.e., Uganda [57], and in Central Africa, i.e., Cameroun [23,26]. For STH, we recommend a biannual PC strategy including pre and SAC, women of child bearing age including pregnant women in the 2nd and 3rd trimesters and lactating women and adults at high risk in certain occupations (e.g.…”
Section: Discussionmentioning
confidence: 99%